NeoCART
Next generation CAR-T modules.
Engineering of the next generation CAR-T molecules: combination of a novel extracellular antigen binding domain and unique paired intracellular signaling modules is expected to lead to enhanced target specificity as well as long term survival of the activated cytotoxic T lymphocytes.
Recombinant protein as a Pan Fc Receptor Interacting molecule
Cancer treatment via symbiosis with tumor tissues through slowing down the progression of cancer-triggered cachexia.
Massive antibody mining, an unique platform for accelerating R&D timelines of therapeutic antibodies.
Niche platform technology for life cycle maintenance of approved antibody drugs.
Next generation CAR-T modules.